Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/national-medical-products-administration-nmpa-approves-chipscreen-biosciences-chidamide-epidaza-combined-with-r-chop-for-the-treatment-of-diffuse-large-b-cell-lymphoma-302131654.html
https://www.prnewswire.com/news-releases/positive-results-from-phase-ii-clinical-trial-cgz203-study-of-chiglitazar-monotherapy-for-non-alcoholic-steatohepatitis-302091430.html
https://www.prnewswire.com/news-releases/chipscreens-new-drug-candidate-cs32582-capsules-approved-for-clinical-treatment-of-psoriasis-301975431.html
https://www.fiercebiotech.com/biotech/keytruda-killer-chipscreen-bags-chinese-rights-biocytogens-bispecific-antibody
https://www.prnewswire.com/news-releases/chipscreen-biosciences-announces-nmpa-new-drug-approval-of-bilessglu-chiglitazar-sodium-tablets-for--type-2-diabetes-in-china-301403089.html
https://www.biospace.com/article/releases/chipscreen-received-a-phase-1b-2-clinical-trial-of-chiauranib-cs2164-ind-clearance-from-the-us-food-and-drug-administration-fda-/#:~:text=)%20News%20(1%2C077)-,Chipscreen%20received%20a%20Phase%201b%2F2%20clinical%20trial%20of%20Chiauranib,Food%20and%20Drug%20Administration%20(FDA)&text=Chiauranib%20is%20an%20innovative%2C%203,III%20clinical%20trials%20in%20China.
https://www.prnewswire.com/news-releases/chipscreen-and-hisun-reach-a-strategic-cooperation-301193850.html#:~:text=Shenzhen%20Chipscreen%20Biosciences%20Co.%2C%20Ltd.&text=SHENZHEN%2C%20China%2C%20Dec.%2016,CHIPSCREEN%20BIOSCIENCES%20CO.%2C%20LTD.&text=(hereinafter%20referred%20to%20as%3A%20HISUN,have%20reached%20a%20strategic%20cooperation.
https://www.prnewswire.com/news-releases/chipscreen-and-hisun-reach-a-strategic-cooperation-301193850.html
https://www.prnewswire.com/news-releases/chipscreen-biosciencess-original-new-drug-cs12192-investigational-new-drug-ind-application-accepted-301028851.html
https://www.prnewswire.com/news-releases/national-medical-products-administration-nmpa-approves-chipscreen-biosciences-chidamide-epidaza-for-breast-cancer-indication-300966800.html